SEGN.V Seegnal Inc.
- Market cap
- CAD 9.36M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is SEGN.V undervalued?
Graham numberThe Graham number of Seegnal Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Seegnal Inc. fundamental analysis
No fundamental analysis for Seegnal Inc. yet.
Seegnal Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Seegnal Inc.
Seegnal Inc. provides SaaS clinical division support solutions. Its clinical decision support platform designed to empower clinicians in managing and resolving patient-specific drug-related problems. Its platform integrates with electronic medical records or other relevant systems that gather an array of applicable data into a patented interface, as well as clinicians gain instant access to vital information, enabling to make informed decisions at the point of care. The comp…
Full company profileSeegnal Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Seegnal Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|
| Income Statement | |||
| Revenue | 1.37M | 1.26M | 1.41M |
| Gross Profit | 32.0K | 8.00K | -64.0K |
| Operating Income | -2.59M | -2.85M | -3.27M |
| EBITDA | -424K | -5.90M | -3.29M |
| Net Income | -860K | -6.21M | -3.63M |
| EPS | -0.02 | -0.14 | -0.08 |
| Balance Sheet | |||
| Total Assets | 580K | 897K | 664K |
| Total Liabilities | 15.8M | 3.23M | 4.71M |
| Shareholders' Equity | -17.9M | -5.61M | -7.33M |
| Cash & Short-term Investments | 200K | 678K | 181K |
| Cash Flow | |||
| Operating Cash Flow | -1.83M | -2.16M | -2.53M |
| Capital Expenditure | 0.00 | 4.00K | 0.00 |
| Free Cash Flow | -1.83M | -2.16M | -2.53M |
| Ratios | |||
| ROA | -148.3% | -692.1% | -546.1% |
| Net Profit Margin | -63.0% | -491.5% | -256.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Seegnal Inc. dividends
Seegnal Inc. has not paid dividends in the last 2 fiscal years.
Who owns Seegnal Inc.
- Insiders 46.97%
- Institutions 0.00%
- Public & others 53.03%
- Shares outstanding 46.8M
- Free float 38.5M
Seegnal Inc. company profile
- Company name
- Seegnal Inc.
- Ticker
- SEGN.V
- Exchange
- TSX Venture Exchange
- Sector
- Healthcare
- Industry
- Health Information Services
- Employees
- 10
- Fiscal year end
- December
- Address
- 300 Roslyn Bldg, Calgary, AB, Canada, T2P 0L6
- Website
- seegnal.com
About Seegnal Inc.
Seegnal Inc. provides SaaS clinical division support solutions. Its clinical decision support platform designed to empower clinicians in managing and resolving patient-specific drug-related problems. Its platform integrates with electronic medical records or other relevant systems that gather an array of applicable data into a patented interface, as well as clinicians gain instant access to vital information, enabling to make informed decisions at the point of care. The company is based in Calgary, Canada.
Seegnal Inc. management
3- Mr. Elad Bibi-Aviv Esq.Chief Executive Officer
- Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.Chief Financial Officer · born 1973
- Mr. Michael John SalikenCorporate Secretary